Cargando…
PMEL as a Prognostic Biomarker and Negatively Associated With Immune Infiltration in Skin Cutaneous Melanoma (SKCM)
Premelanosome protein (PMEL) is crucial for the formation of melanosomal fibrils through the transition from stage I to stage II melanosomes. It was used as a target antigen in some adoptive T-cell therapy of melanoma. The correlation of PMEL to prognosis and immune cell infiltration level are unkno...
Autores principales: | Zhang, Shuguang, Chen, Kun, Liu, Huanmei, Jing, Changyou, Zhang, Xinxin, Qu, Chunfeng, Yu, Shengji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225232/ https://www.ncbi.nlm.nih.gov/pubmed/34028390 http://dx.doi.org/10.1097/CJI.0000000000000374 |
Ejemplares similares
-
The role of SRGN in the survival and immune infiltrates of skin cutaneous melanoma (SKCM) and SKCM-metastasis patients
por: Wang, Xiaofang, et al.
Publicado: (2020) -
TIMM13 as a prognostic biomarker and associated with immune infiltration in skin cutaneous melanoma (SKCM)
por: Zhou, Sitong, et al.
Publicado: (2022) -
The role of NLRP3 in the prognosis and immune infiltrates of skin cutaneous melanoma (SKCM)
por: Wu, Shaobo, et al.
Publicado: (2021) -
Construction of Prognostic Risk Model of Patients with Skin Cutaneous Melanoma Based on TCGA-SKCM Methylation Cohort
por: Yu, Xiaoming, et al.
Publicado: (2022) -
Analysis of prognostic factors in 171 patients with myxofibrosarcoma of the trunk and extremities: a cohort study
por: Liu, Huanmei, et al.
Publicado: (2021)